��������

Dana Wollet is a seasoned professional in healthcare communications, currently serving as Vice President at FleishmanHillard since March 2020. Previous experience includes roles as Corporate Affairs Manager for Global & U.S. Oncology at Amgen and Account Supervisor at Chamberlain Healthcare Public Relations, where Dana managed campaigns for notable pharmaceutical clients such as Mitsubishi Tanabe Pharma and Boston Biomedical. Dana's expertise extends to prior positions in public relations at Ruder Finn and Ketchum, focusing on drugs and public health initiatives for companies like Novartis and Takeda Pharmaceuticals. Early career development included roles at WebMD and internships with the Indiana State Department of Health and Indiana University Health Hospital. Dana holds a Bachelor's degree in Health Science with a focus on Public Health from Ball State University.